Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study

Saved in:

書目詳細資料
Main Authors:	Matteo Santoni, Zin Myint, Thomas Büttner, Hideki Takeshita, Y. Okada, Elaine T. Lam, Danielle Gilbert, Zsófia Kürönya, Deniz Tural, Renate Pichler, Enrique Grande, Simon J. Crabb, ROBERT COLEMAN KEMP, Francesco Massari, Sarah Scagliarini, Roberto Iacovelli, Nuno Vau, Umberto Basso, Marco Maruzzo, Javier Molina‐Cerrillo, Luca Galli, Aristotelis Bamias, Ugo De Giorgi, Paolo Andrea Zucali, Mimma Rizzo, Emmanuel Seront, Lazar Popović, Orazio Caffo, Sebastiano Buti, Ravindran Kanesvaran, Jindřich Kopecký, Jakub Kucharz, Annalisa Zeppellini, Ondřej Fiala, Johannes Landmesser, Jawaher Ansari, Patrizia Giannatempo, Alessandro Rizzo, Ignacio Ortego Zabalza, Fernando Sabino Marques Monteiro, Nicola Battelli, Fabio Calabrò, Camillo Porta
格式:	Artigo
語言:	英语
出版:	2023
在線閱讀:	https://doi.org/10.1007/s00262-023-03469-5
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

因特網